DD ISO/TS 12417:2011
Superseded
A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.
View Superseded by
Cardiovascular implants and extracorporeal systems. Vascular device-drug combination products
Hardcopy , PDF
English
31-07-2011
31-10-2015
Foreword
Introduction
1 Scope
2 Normative references
3 Terms and definitions
4 General requirements
5 Intended performance
6 Design attributes
7 Materials
8 Design evaluation
9 Post-market surveillance
10 Manufacturing
11 Sterilization
12 Packaging
Annex A (informative) - Definitions of potential
clinical events
Annex B (informative) - Information on device- and
drug-related aspects - Applicable documents
for local guidance
Bibliography
Describes requirements for vascular device-drug combination products (VDDCPs) based upon current technical and medical knowledge. VDDCPs are medical devices with various clinical indications for use in the human vascular blood system. A VDDCP incorporates, as an integral part, substance(s) which, if used separately, can be considered to be a medicinal product (drug product) but the action of the medicinal substance is ancillary to that of the device and supports the primary mode of action of the device.
| Committee |
CH/150/2
|
| DocumentType |
Standard
|
| Pages |
60
|
| PublisherName |
British Standards Institution
|
| RevisionOf | |
| Status |
Superseded
|
| SupersededBy |
| Standards | Relationship |
| ISO/TS 12417:2011 | Identical |
A newer version of this standard is available.
View Current Edition